Officials from the Drugs Wing of the Food Safety and Drug Administration (FDA) seized counterfeit medicines worth more than ₹5 crore [1] near Bengaluru.
The raid targets a sophisticated racket that threatens public health by distributing unlicensed medications disguised as legitimate products from multinational corporations.
Authorities discovered the operation near the Bidadi Toll Gate in Karnataka, India [1]. The investigation revealed an unlicensed manufacturing unit dedicated to the repacking and relabelling of fake medicines [2]. The FDA said the facility was used to apply multinational company labels to counterfeit drugs to deceive buyers and healthcare providers [2].
The seizure included a massive volume of medications with an estimated value of ₹5 crore [2]. Officials said the operation was designed to stop the illegal sale of these counterfeit products and enforce drug safety regulations [1].
By utilizing the labels of established global pharmaceutical firms, the operators of the unit attempted to bypass safety scrutiny. FDA officials conducted the raids to dismantle the supply chain and prevent these unregulated substances from reaching patients [2].
The Drugs Wing continues to investigate the scale of the distribution network to determine how many of these counterfeit medicines had already entered the local market. The operation highlights ongoing challenges in regulating pharmaceutical supply chains in the region, particularly regarding unlicensed facilities operating on the outskirts of major urban centers [1].
“FDA officials seized counterfeit medicines worth more than ₹5 crore.”
This seizure underscores a critical vulnerability in the pharmaceutical supply chain where counterfeiters exploit the brand trust of multinational companies to sell unregulated drugs. The use of an unlicensed facility near a major transit point like the Bidadi Toll Gate suggests a strategic attempt to facilitate the rapid movement of illegal goods into the Bengaluru metropolitan area, necessitating stricter oversight of peri-urban industrial zones.
